Home Development and validation of a mobile application for point of care evaluation of growth failure
Article
Licensed
Unlicensed Requires Authentication

Development and validation of a mobile application for point of care evaluation of growth failure

  • Riddhi V. Patel , Anurag T. Bajpai EMAIL logo , Hemangkumar V. Mendpara , Chetankumar C. Dave , Sajili S. Mehta , Shalabh Dixit and Rishi K. Shukla
Published/Copyright: September 17, 2021

Abstract

Objectives

Lack of systematic evaluation of short stature results in unnecessary work-up on one hand while missing pathology on the other. We have developed a mobile application that guides work-up based on age, auxology (height, BMI, and corrected standard deviation score), and skeletal maturation with an aim of reducing the diagnostic errors. Aim of this study is to develop and validate a mobile application for point of care evaluation of short stature.

Methods

The application was developed (n=400) and validated (n=412) on children and adolescents (2–18 years of age) presenting to our Pediatric Endocrinology Clinic with short stature. Height standard deviation score thresholds determining the need for workup were derived from Receiver Operating Characteristics (ROC) curve. Student’s t-test and ROC curves were used to identify the most appropriate parameter differentiating constitutional delay of growth and puberty (CDGP) from pathological and nutritional from endocrine causes. The validation of the application involved comparing the application predicted and clinical diagnosis at each step of the algorithm.

Results

The mobile application diagnosis was concordant with clinical diagnosis in 408 (99.0%) with discordance in four (two with CDGP labeled as growth hormone deficiency [GHD] and two with GHD labeled as CDGP).

Conclusions

Mobile application guided short stature assessment has a high concordance with the clinical diagnosis and is expected to help point of care short stature evaluation.


Corresponding author: Dr. Anurag Bajpai, MD, Pediatrics, FRACP Pediatric Endocrinology, Department of Pediatric Endocrinology, Regency Center for Diabetes Endocrinology & Research, Regency City Clinic, Opposite PPN Market, Kanpur 208001, India; and GROW Society, Growth & Obesity Workforce, Kanpur, India, Mobile: +919936737767, E-mail:

Acknowledgments

We would like to thank Dr. Vaman Khadilkar for providing a Macro template for calculating Z scores asper IAP 2015 criteria.

  1. Research funding: Not funded.

  2. Author contributions: Riddhi V. Patel, Hemangkumar V. Mendpara, Chetankumar C. Dave, and Sajili S. Mehta were involved in patient management and data collection. Riddhi V. Patel did a literature review, statistical analysis and drafted the initial manuscript. Rishi K. Shukla and Anurag T. Bajpai were involved in patient care. Salabh Dixit developed and tested the mobile application. Anurag T. Bajpai conceptualized and planned the study, designed the application, critically reviewed the manuscript, and would act as the guarantor of the paper. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study was approved by the Institutional Ethics Committee of our hospital (RHL-IEC-16039, September 11, 2019).

References

1. Bajpai, A, Agarwal, N. Growth failure. In: MedEClasses Pediatric endocrinology, Bajpai, A, Patel, R, Dave, C, Agarwal, N, editors. Kanpur: Grow society Press, 2019:49–53 pp.Search in Google Scholar

2. Sisley, S, Trujillo, MV, Khoury, J, Backeljauw, P. Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. J Pediatr 2013;163:1045–51. https://doi.org/10.1016/j.jpeds.2013.04.002.Search in Google Scholar PubMed PubMed Central

3. Wit, JM, Kamp, GA, Oostdijk, W. Towards a rational and efficient diagnostic approach in children referred for growth failure to the general paediatrician. Horm Res Paediatr 2019;91:223–40. https://doi.org/10.1159/000499915.Search in Google Scholar PubMed

4. Collett-Solberg, PF, Ambler, G, Backeljauw, PF, Bidlingmaier, M, Biller, BMK, Boguszewski, MCS, et al.. Diagnosis, genetics, and therapy of short stature in children: a growth hormone Research Society International perspective. Horm Res Paediatr 2019;92:1–14. https://doi.org/10.1159/000502231.Search in Google Scholar PubMed PubMed Central

5. Andersson, HC. Algorithm-driven electronic health record notification enhances detection of Turner syndrome. J Pediatr 2020;216:1–3. https://doi.org/10.1016/j.jpeds.2019.10.086.Search in Google Scholar PubMed

6. Khadilkar, V, Yadav, S, Agrawal, KK, Tamboli, S, Banerjee, M, Cherian, A, et al.. Revised IAP growth charts for height, weight, and body mass index for 5- to 18-year old Indian children. Indian Pediatr 2015;52:47–55. https://doi.org/10.1007/s13312-015-0566-5.Search in Google Scholar PubMed

7. Husby, S, Koletzko, S, Korponay-Szabó, I, Kurppa, K, Mearin, ML, Ribes-Koninckx, C, et al.. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr 2020;70:141–56. https://doi.org/10.1097/mpg.0000000000002497.Search in Google Scholar PubMed

8. Grimberg, A, DiVall, SA, Polychronakos, C, Allen, DB, Cohen, LE, Quintos, JB, et al.. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr 2016;86:361–97. https://doi.org/10.1159/000452150.Search in Google Scholar PubMed

9. Wright, CM, Cheetham, TD. The strengths and limitations of parental heights as a predictor of attained height. Arch Dis Child 1999;81:257–60. https://doi.org/10.1136/adc.81.3.257.Search in Google Scholar PubMed PubMed Central

10. Gravholt, CH, Andersen, NH, Conway, GS, Dekkers, OM, Geffner, ME, Klein, KO, et al.. International Turner Syndrome Consensus Group. Clinical Practice Guidelines for the care of girls and women with turner syndrome: proceedings from the 2016 Cincinnati Inter-national turner syndrome meeting. Eur J Endocrinol 2017;177:1–70. https://doi.org/10.1530/endoabs.49.gs1.1.Search in Google Scholar

11. Khadilkar, V, Khadilkar, A, Arya, A, Ekbote, V, Kajale, N, Parthasarathy, L, et al.. Height velocity percentiles in Indian children aged 5–17 years. Indian Pediatr 2019;56:23–9. https://doi.org/10.1007/s13312-019-1461-2.Search in Google Scholar

12. Van Buuren, S, van Dommelen, P, Zandwijken, GR, Grote, FK, Wit, JM, Verkerk, PH. Towards evidence based referral criteria for growth monitoring. Arch Dis Child 2004;89:336–41. https://doi.org/10.1136/adc.2003.027839.Search in Google Scholar PubMed PubMed Central

13. Bhadada, SK, Bhansali, A, Ravikumar, P, Kochhar, R, Nain, CK, Dutta, P, et al.. Changing scenario in aetiological profile of short stature in India-growing importance of celiac disease: a study from tertiary care centre. Indian J Pediatr 2011;78:41–4. https://doi.org/10.1007/s12098-010-0227-6.Search in Google Scholar PubMed

Received: 2021-04-12
Accepted: 2021-09-03
Published Online: 2021-09-17
Published in Print: 2022-02-23

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Obesity after the Covid-19 pandemic and beyond
  4. Review Article
  5. Clinical profile and management challenges of disorders of sex development in Africa: a systematic review
  6. Original Articles
  7. Development and validation of a mobile application for point of care evaluation of growth failure
  8. Children-Dietary Inflammatory Index (C-DII), cardiometabolic risk, and inflammation in adolescents: a cross-sectional study
  9. Accelerated pubertal onset in short children with delayed bone age
  10. Screening for hypophosphatasia: does biochemistry lead the way?
  11. Subcutaneous regular insulin use for the management of diabetic ketoacidosis in resource limited setting
  12. NPR2 gene variants in familial short stature: a single-center study
  13. The effect of the COVID-19 pandemic on metabolic control in children with type 1 diabetes: a single-center experience
  14. Evaluating a standardized protocol for the management of diabetes insipidus in pediatric neurosurgical patients
  15. Development and assessment of a low-health-literacy, pictographic adrenal insufficiency action plan
  16. Effect of insulin resistance on lung function in asthmatic children
  17. A major health problem facing immigrant children: nutritional rickets
  18. Clinical profile, etiology, and diagnostic challenges of primary adrenal insufficiency in Sudanese children: 14-years’ experience from a resource limited setting
  19. Non-inferiority of liquid thyroxine in comparison to tablets formulation in the treatment of children with congenital hypothyroidism
  20. Short Communication
  21. Increased frequency of idiopathic central precocious puberty in girls during the COVID-19 pandemic: preliminary results of a tertiary center study
  22. Case Reports
  23. Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report
  24. Nitisinone treatment during two pregnancies and breastfeeding in a woman with tyrosinemia type 1 – a case report
  25. Myxedema crisis and ovarian hyperstimulation in a child with Down syndrome
  26. First successful concomitant therapy of immune tolerance induction therapy and desensitization in a CRIM-negative infantile Pompe patient
Downloaded on 21.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0267/html
Scroll to top button